| Adam Endress, PT | |
|
2300 Park Ave, Suite 203, Orange Park, FL 32073-5571 | |
| (904) 634-0640 | |
| (904) 634-0203 |
| Full Name | Adam Endress |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 17 Years |
| Location | 2300 Park Ave, Orange Park, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053505586 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Orthopedic Specialists Llc | 1456246974 | 111 |
News Archive
A Maryland woman traveled to the Dominican Republic early in her pregnancy, spending three weeks with family. She felt dizzy and tired and, at first, attributed the lethargy to jet lag.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
The risk of major arterial adverse events in chronic myeloid leukaemia patients may significantly differ between tyrosine kinase inhibitors, suggests a meta-analysis published in Leukemia & Lymphoma.
In a study published in the New England Journal of Medicine, a research consortium that includes the University of Alabama at Birmingham (UAB) has shown that a new drug for vasculitis, a potentially life-threatening auto-immune disease which causes inflammation in blood vessels, is as effective as standard therapy over 18 months.
› Verified 4 days ago
| Provider Name | Southeast Orthopedic Specialists Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1629025820 PECOS PAC ID: 1456246974 Enrollment ID: O20040216000301 |
News Archive
A Maryland woman traveled to the Dominican Republic early in her pregnancy, spending three weeks with family. She felt dizzy and tired and, at first, attributed the lethargy to jet lag.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
The risk of major arterial adverse events in chronic myeloid leukaemia patients may significantly differ between tyrosine kinase inhibitors, suggests a meta-analysis published in Leukemia & Lymphoma.
In a study published in the New England Journal of Medicine, a research consortium that includes the University of Alabama at Birmingham (UAB) has shown that a new drug for vasculitis, a potentially life-threatening auto-immune disease which causes inflammation in blood vessels, is as effective as standard therapy over 18 months.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Endress, PT 6500 Bowden Rd, Suite 103, Jacksonville, FL 32216-8070 Ph: (904) 634-0640 | Adam Endress, PT 2300 Park Ave, Suite 203, Orange Park, FL 32073-5571 Ph: (904) 634-0640 |
News Archive
A Maryland woman traveled to the Dominican Republic early in her pregnancy, spending three weeks with family. She felt dizzy and tired and, at first, attributed the lethargy to jet lag.
The U.S. Food and Drug Administration has licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
The risk of major arterial adverse events in chronic myeloid leukaemia patients may significantly differ between tyrosine kinase inhibitors, suggests a meta-analysis published in Leukemia & Lymphoma.
In a study published in the New England Journal of Medicine, a research consortium that includes the University of Alabama at Birmingham (UAB) has shown that a new drug for vasculitis, a potentially life-threatening auto-immune disease which causes inflammation in blood vessels, is as effective as standard therapy over 18 months.
› Verified 4 days ago
Cindy Guo, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 500 Park Ave, Orange Park, FL 32073 Phone: 904-278-7890 | |
Susan Murray, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 839 Westminster Dr, Orange Park, FL 32073 Phone: 904-276-0938 Fax: 904-276-4785 | |
Renee Lehosit, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1555 Kingsley Ave, Orange Park, FL 32073 Phone: 904-215-8600 | |
Nedzad Cavka, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2300 Park Ave, Suite 203, Orange Park, FL 32073 Phone: 904-634-0640 Fax: 904-634-0203 | |
Crystle Taiyo Kearley, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1675 Eagle Harbor Pkwy, Orange Park, FL 32003 Phone: 904-637-0148 | |
Susan I Murray Pa Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 839 Westminster Dr, Orange Park, FL 32073 Phone: 904-376-5194 | |
Steven Short, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 540 Kingsley Ave, Orange Park, FL 32073 Phone: 904-264-2156 |